Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?

To: LemurHouse who wrote (616)	12/13/2001 7:05:20 PM
From: John Curtis	Respond to of 656

As an IMNX shareholder I'm not at all happy about this. I think IMNX alone has much greater potential IMO. And I hope the board agrees. Low $30's is certainly too low. As a holder of a long term core position in this equity, established shortly after it fell apart, I've got to say I agree with you. However, I've also got to admit I'm please IMNX is getting some visibility. Look at it this way, AMGN has just opened the bidding.... Let's see where it goes from here! John~